verapamil has been researched along with sdz 280 446 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Didier, A; Loor, F; Pourtier-Manzanedo, A | 1 |
| Jachez, B; Loor, F | 1 |
| Boesch, D; Loor, F | 1 |
| Jachez, B; Loor, F; Nordmann, R | 1 |
| Didier, A; Loor, F; Wenger, J | 1 |
| Loor, F; Tiberghien, F | 1 |
6 other study(ies) available for verapamil and sdz 280 446
| Article | Year |
|---|---|
Expression of P-glycoprotein on normal lymphocytes: enhancement of the doxorubicin-sensitivity of concanavalin A-responding mouse spleen cells by P-glycoprotein blockers.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; CD8 Antigens; Concanavalin A; Cyclosporins; Doxorubicin; Drug Resistance; Drug Synergism; Female; Lymphocyte Activation; Lymphocyte Depletion; Lymphocytes; Membrane Glycoproteins; Mice; Peptides, Cyclic; Spleen; T-Lymphocyte Subsets; Verapamil | 1992 |
Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
Topics: Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cell Division; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance; Flow Cytometry; Humans; Leukemia-Lymphoma, Adult T-Cell; Membrane Glycoproteins; Peptides, Cyclic; Tumor Cells, Cultured; Verapamil | 1993 |
Extent and persistence of P-glycoprotein inhibition in multidrug-resistant P388 cells after exposure to resistance-modifying agents.
Topics: Amino Acid Sequence; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Cyclosporine; Cyclosporins; Daunorubicin; Drug Resistance; Extracellular Space; Leukemia P388; Membrane Glycoproteins; Mice; Molecular Sequence Data; Peptides, Cyclic; Verapamil | 1994 |
Restoration of taxol sensitivity of multidrug-resistant cells by the cyclosporine SDZ PSC 833 and the cyclopeptolide SDZ 280-446.
Topics: Animals; Antineoplastic Agents; CHO Cells; Cricetinae; Cyclosporins; Drug Resistance; Leukemia P388; Mice; Paclitaxel; Peptides, Cyclic; Tumor Cells, Cultured; Verapamil | 1993 |
Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockers.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Cyclosporins; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Flow Cytometry; Humans; Immunosuppressive Agents; Leukemia, Monocytic, Acute; Leukemia, T-Cell; Mice; Peptides, Cyclic; Rhodamines; Tumor Cells, Cultured; Verapamil; Vinblastine | 1995 |
Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Drug Screening Assays, Antitumor; Fluoresceins; Fluorescent Dyes; Humans; Mice; Peptides, Cyclic; Tumor Cells, Cultured; Verapamil; Vinblastine | 1996 |